Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

GW Pharmaceuticals

MedMen Enterprises Inc.

Just a friendly reminder that popularity doesn't necessarily equate to profitability in the cannabis space.

3 Popular Pot Stocks That Won't Be Profitable in 2020

Aurora Cannabis

Aphria

Cronos Group

HEXO Corp

Tilray Brands

Cannabis stocks had a huge showing on Wall Street last fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Raise Their Bets in Cannabis Stocks

Operating results for the largest pot stock in the world are due out next week -- here's what you need to know.

10 Numbers to Focus On When Canopy Growth Reports Its Fourth-Quarter Results

Canadian cannabis company Canopy Growth Corp (NYSE: CGC) is weighing its options for non-equity financing as it looks to expand to take advantage of market opportunities in the United States and Europe.

'We're Trying To Be Smart About It': New Canopy Growth CFO Says Cannabis Company Eyeing Financing Options

If you own CGC stock, next week's earnings report could be a doozie. Here are the things that could make or break  Canopy stock.

3 Things to Scrutinize in Canopy Growth’s Earnings Report

Cannabis investing emerged as a clear trend in the past year, with marijuana stocks accounting for a fifth of the 20 most-held stocks on the Robinhood app.

These Marijuana Stocks Are Smoking Hot Among Millennial Investors

This cannabis stock stands out from all the rest. But is it really the only one worth buying right now?

The Only Marijuana Stock 1 Top Analyst Recommends Buying

If the upcoming earnings report does not meet the optimistic revenue and sales expectations of investors, CGC stock may decline further. 
The post CGC Stock Will Be Volatile Heading Into Earnings appeared first on InvestorPlace.

CGC Stock Will Be Volatile Heading Into Earnings

Lowe's

Lyft

Bears hold the upper hand in today's selection of stocks to sell. Each has a low risk, high reward opportunity as they near resistance.

3 Stocks That Can’t Escape the Bears’ Crosshairs

Marijuana stocks got clobbered last month, and their performances are a mixed bag so far in June.

Why Canopy, Aurora, and Aphria Stocks Fell up to 20% in May -- and How They're Faring in June

Despite what others are saying about Canopy Growth, "the best investable opportunity" in CGC stock may be to short shares.
The post Why Canopy Growth Stock Is the Perfect Pick for a Short appeared first on InvestorPlace.

Why Canopy Growth Stock Is the Perfect Pick for a Short

As a person with Parkinson's Disease, I am rooting for Canopy Growth to succeed, despite my misgivings about CGC stock price.
The post My Interest in Canopy Growth Stock Goes Beyond Its Price appeared first on InvestorPlace.

My Interest in Canopy Growth Stock Goes Beyond Its Price

CannTrust Holdings

These stocks are down but definitely not out.

3 Cannabis Stocks to Buy on the Rebound in June

While vital to the long-term success of the cannabis industry, don't overestimate the near-term impact of pushing into overseas markets.

Marijuana Stocks: You're Missing 2 Key Points About International Expansion

With the industry possibly cooling off, here are the names to remember.

3 Top Marijuana Stocks to Watch in June 2019

An investigative report revealed that Canopy Growth was involved in a 1500 pound marijuana bust. Marijuana remains a risky market, politically.

Canopy Growth Implicated in Massive Pot Bust and Cover Up

Canopy Growth Corp (NYSE: CGC) recently announced a deal to acquire U.S. cannabis company Acreage Holdings Inc (OTC: ACRGF) that is contingent on U.S.

Analyst: Acreage Deal Part Of Canopy Growth's 'One Step Ahead' Mentality

CGC stock is in sell-off mode, but as the stock closes in on $40, this sell-off of Canopy stock could be approaching its final inning.
The post Why Investors Should Buy Canopy Growth Stock appeared first on InvestorPlace.

Why Investors Should Buy Canopy Growth Stock

Marijuana investors' favorite stocks are anywhere from 25% to 84% below their all-time highs.

Every Popular Pot Stock Is Now in Bear Market Territory

Canopy Growth stock is the pot industry's "best investable opportunity," Stifel analysts said, even as they remained cautious on other marijuana stocks.  
The post Why Canopy Growth Is The Most 'Investable' Of Canada's Marijuana Stocks appeared first on Investor's Business Daily.

Why Canopy Growth Is The Most 'Investable' Of Canada's Marijuana Stocks

A wave of Wall Street analysts are initiating coverage of the cannabis space for the first time, and Stifel is the latest firm to weigh in on Canopy Growth Corp (NYSE: CGC).

Stifel: Canopy Growth Is The 'Best Investable Opportunity' In Cannabis

Canopy Growth stock has taken a hit lately.   But this looks like a good opportunity to buy CGC stock on weakness.

Should Investors Buy Canopy Stock as Cannabis Legalization Gains Momentum?

Canadian-based cannabis and hemp company Canopy Growth Corp (NYSE: CGC) is looking to open hemp facilities across seven U.S.

Canopy Growth Details Some US Expansion Plans

Plunging share prices make it easy to fall into this trap.

The Biggest Mistake Marijuana Stock Investors Are Making Right Now

Of course, the medical opportunity is massive, but Tilray competitor, Canopy Growth (NYSE:CGC), has been aggressively pursuing a multi-pronged approach that inherently diversifies the future revenue streams. CGC’s vision for THC as an ingredient in an array of consumer products separates them from an increasingly crowded industry.

News for Canopy Growth Stock (CGC)